Liver X receptor beta (LXRβ) shows potential in reducing depression and anxiety by improving neurogenesis, reducing ...

Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will ...

A research team led by Prof. Zhou Rongbin from the University of Science and Technology of China (USTC) discovered the ...

A research team led by Prof. ZHOU Rongbin from the University of Science and Technology of China (USTC) discovered the ...

"AI can rapidly make full use of both compound and protein data gained from imaging, evolutionary and chemical experiments to ...

Coave's proprietary ALIGATER platform enables specific retargeting of AAV vectors to human receptors via a one-step chemical conjugation of peptide-based ligands at the surface of the capsid, ...

An estimated one in five Americans live with chronic pain and current treatment options leave much to be desired. Scientists are now using artificial intelligence (AI) for drug discovery in advanced ...

Biotech firm Gilead Sciences has announced plans to voluntarily withdraw the US accelerated approval for Trodelvy ...

Volume electron microscopy reveals a novel cellular process that is critical for healthy brain development, with implications ...

This important study provides solid in-vivo evidence that CCR4 regulates the early inflammatory response during atherosclerotic plaque formation. The authors propose that altered T-cell response plays ...